LUND, SWEDEN -- (MARKET WIRE) -- December 18, 2006 -- Based on the mandate granted by the Annual General Meeting, held on April 26, 2006, the Board of Active Biotech has resolved to conduct a guaranteed preferential rights issue for approximately SEK 240 M.
